These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15859357)

  • 1. Modifiers of mammary tumor progression and metastasis on mouse chromosomes 7, 9, and 17.
    Lancaster M; Rouse J; Hunter KW
    Mamm Genome; 2005 Feb; 16(2):120-6. PubMed ID: 15859357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel modifier loci of Apc Min affecting mammary tumor development.
    Wang H; Teske D; Tess A; Kohlhepp R; Choi Y; Kendziorski C; Moser AR
    Cancer Res; 2007 Dec; 67(23):11226-33. PubMed ID: 18056448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1.
    Hunter KW; Broman KW; Voyer TL; Lukes L; Cozma D; Debies MT; Rouse J; Welch DR
    Cancer Res; 2001 Dec; 61(24):8866-72. PubMed ID: 11751410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility loci affecting ERBB2/neu-induced mammary tumorigenesis in mice.
    Quan L; Dittmar A; Zhou Y; Hutson A; Stassen AP; Demant P
    Genes Chromosomes Cancer; 2012 Jul; 51(7):631-43. PubMed ID: 22419448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of two regions on rat chromosomes 5 and 18 affecting mammary cancer susceptibility.
    Stieber D; Piessevaux G; Rivière M; Laes JF; Quan X; Szpirer J; Szpirer C
    Int J Cancer; 2007 Apr; 120(8):1678-83. PubMed ID: 17230524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of mammary lesions represent molecular differences.
    Namba R; Maglione JE; Davis RR; Baron CA; Liu S; Carmack CE; Young LJ; Borowsky AD; Cardiff RD; Gregg JP
    BMC Cancer; 2006 Dec; 6():275. PubMed ID: 17147824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
    Guy CT; Webster MA; Schaller M; Parsons TJ; Cardiff RD; Muller WJ
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10578-82. PubMed ID: 1359541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelotypic and cytogenetic characterization of chemically induced mouse mammary tumors: high frequency of chromosome 4 loss of heterozygosity at advanced stages of progression.
    Aldaz CM; Liao QY; Paladugu A; Rehm S; Wang H
    Mol Carcinog; 1996 Nov; 17(3):126-33. PubMed ID: 8944072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ROSA26 LacZ-neo(R) insertion confers resistance to mammary tumors in Apc(Min/+) mice.
    Kohlhepp RL; Hegge LF; Moser AR
    Mamm Genome; 2001 Aug; 12(8):606-11. PubMed ID: 11471054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours.
    Davies MP; Rudland PS; Robertson L; Parry EW; Jolicoeur P; Barraclough R
    Oncogene; 1996 Oct; 13(8):1631-7. PubMed ID: 8895508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis.
    Aprelikova O; Chen K; El Touny LH; Brignatz-Guittard C; Han J; Qiu T; Yang HH; Lee MP; Zhu M; Green JE
    Clin Epigenetics; 2016; 8():38. PubMed ID: 27081402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion.
    Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS
    Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammary tumorigenesis and metastasis in transgenic mice.
    Webster MA; Muller WJ
    Semin Cancer Biol; 1994 Feb; 5(1):69-76. PubMed ID: 8186390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Karyotypic evolution of a murine mammary adenocarcinoma in vitro and during progression from primary to metastatic growth in vivo.
    Elliott BE; Xu W; Mudrik K; Marshall J; Vekemans M; Holden JJ
    Genes Chromosomes Cancer; 1992 Jun; 4(4):281-9. PubMed ID: 1377934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in p53 mutations in mouse mammary tumor subpopulations with different metastatic potential from the orthotopic site.
    Shekhar PV; Werdell J; Christman JK; Miller FR
    Anticancer Res; 1995; 15(3):815-20. PubMed ID: 7645964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene.
    Ambartsumian NS; Grigorian MS; Larsen IF; Karlstrøm O; Sidenius N; Rygaard J; Georgiev G; Lukanidin E
    Oncogene; 1996 Oct; 13(8):1621-30. PubMed ID: 8895507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel analysis of transcript and translation profiles: identification of metastasis-related signal pathways differentially regulated by drug and genetic modifications.
    Yang H; Yu LR; Yi M; Lucas DA; Lukes L; Lancaster M; Chan KC; Issaq HJ; Stephens RM; Conrads TP; Veenstra TD; Hunter KW
    J Proteome Res; 2006 Jul; 5(7):1555-67. PubMed ID: 16823962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated frequency of loss of heterozygosity in mammary tumors arising in mouse mammary tumor virus/neu transgenic mice.
    Cool M; Jolicoeur P
    Cancer Res; 1999 May; 59(10):2438-44. PubMed ID: 10344755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary fat-dependent transcriptional architecture and copy number alterations associated with modifiers of mammary cancer metastasis.
    Gordon RR; La Merrill M; Hunter KW; Sørensen P; Threadgill DW; Pomp D
    Clin Exp Metastasis; 2010 May; 27(5):279-93. PubMed ID: 20354763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.